This document discusses the role of nanoparticles in drug delivery. Nanoparticles can enhance drug delivery by allowing targeted delivery and controlled release of drugs. They interact more efficiently with cells and require lower dosages, reducing side effects. Various types of nanoparticles used for drug delivery include metal-based, lipid-based, and polymer-based nanoparticles. Nanoparticles must be optimally designed to avoid rapid clearance from the body and target delivery to specific sites. Continued improvements in controlled release and targeting will enable safer and more effective therapeutic nanoparticles.
Drug delivery
Method ofadministering pharmaceutical compound to achieve
a therapeutic effect .
-Targeted Drug Delivery:
Delivering drug to specific site
Metal-based Nano particles
•AuNPs acting as heat producer featured high conversion efficiency of
NIR light to heat.
• Used mainly in cancer therapy
• Disadvantage: Toxicity
9.
Lipid based Nanoparticles
•A liposome is an artificially-prepared spherical vesicle
composed of a lipid bilayer
• Advantage: Biodegradable
10.
Polymer nanoparticles
• Carriesdrug through forming drug-polymer complex
• Dentrimers : Carries drugs through covalent conjugation
• Advantage:
Carriers of DNA in gene therapy, proteins, peptides and
genes .
11.
Optimal design ofnanoparticles
• Rapid clearance during systemic delivery
• Opsonization - nonspecific protein adsorption
• Rapid clearance by Mononuclear Phagocyte system (MPS) in
the liver and by spleen filtration
12.
Factors
• Size
Nanoparticles smallerthan 10 nm can be rapidly cleared by the
kidneys or through extravasation, while larger nanoparticles may
have higher tendency to be cleared by cells of the MPS
• Surface charge
Neutrally charged particles have demonstrated much lower
opsonization rates than charged particles
13.
• PEGylation
A PEGshell on the nanoparticle surface shields charged
particles from attachment by blood proteins leading to
prolonged circulation half-life.
• Targeting Ligands
Size and charge of the ligand molecule, and their ease of
modification and conjugation to the nanoparticles.
14.
Conclusion
• Designing nanoparticlesto be taken orally.
• Introduction and improvement of controlled release
properties and targeting ligands is expected to enable the
development of safer and more effective therapeutic
nanoparticles.
• The development of particles that are nano scaled has
created great opportunities in the of improved drug delivery
systems.